Guardian Pharmacy Services Inc (GRDN) reported better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $0.25, surpassing Wall Street's consensus estimate of $0.17 by $0.08. Revenue matched expectations at $0.4 billion.
This update provides insight into Guardian Pharmacy's operational performance and financial health. The company, headquartered in Atlanta, Georgia, specializes in providing client service and resident care to long-term care communities. With a workforce of 3,400 full-time employees, Guardian Pharmacy utilizes a technology-enabled platform to manage the dispensing and administration of prescriptions, enhancing care and improving adherence to drug regimens.
The company plans to host an earnings conference call to discuss these results and offer additional commentary on its business performance. Investors are encouraged to review the full earnings release and management commentary for a comprehensive understanding of the quarter's performance and future outlook.
Looking ahead, Guardian Pharmacy has upcoming earnings estimates of $0.23 EPS and $358.7 million in revenue for August 9, 2026, and $0.22 EPS with $342.2 million in revenue for May 10, 2026.